Lantern Pharma (LTRN) Tops Q3 EPS by 19c

Lantern Pharma (NASDAQ: LTRN) reported Q3 EPS of ($0.29), $0.19 better than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• BofA Securities Downgrades Logitech International SA (LOGN:SW) (LOGI) to Underperform
• MediaTek Inc. (2454:TT) (MDTKF) PT Raised to NT$5,800 at Nomura/Instinet